Skip to main content
SpringerLink
Log in

Clinical Presentation and Epidemiology of Myasthenia Gravis

  • Chapter
  • First Online:
Book cover Myasthenia Gravis and Related Disorders

Part of the book series: Current Clinical Neurology ((CCNEU))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

REFERENCES

  1. Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA-antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579–601

    Article  PubMed  CAS  Google Scholar 

  2. Antonini G, Morino S, Gragnani F, Fiorelli M. Myasthenia gravis in the elderly: a hospital based study. Acta Neurol Scand 1996; 93: 260–262

    Article  PubMed  CAS  Google Scholar 

  3. Weijnen FG, van der Bilt A, Wokke J, Kuks J, van der Glas HW, Bosman F. What’s in a smile? Quantification of the vertical smile of patients with myasthenia gravis. J Neurol Sci 2000;173:124–128.

    Article  PubMed  CAS  Google Scholar 

  4. Weijnen FG, Van der Bilt A, Wokke JHJ, Kuks JBM, Van der Glas HW, Bosman F. Maximal bite force and surface EMG in patients with myasthenia gravis. Muscle Nerve 2000;23:1694–1699.

    Article  PubMed  CAS  Google Scholar 

  5. Weijnen FG, Kuks JBM, Van der Bilt, Van der Glas HW, Wassenberg MWM, Bosman F: Tongue force in patients with myasthenia gravis. Acta Neurol Scand 2000; 102: 303–308.

    Article  PubMed  CAS  Google Scholar 

  6. Osei-Lah A, Reilly V, Capildeo BJ. Bilateral abductor vocal fold paralysis due to myasthenia gravis. J Laryngol Otol 1999;113:678–679

    Article  PubMed  CAS  Google Scholar 

  7. Oosterhuis H J G H. Myasthenia gravis. Churchill Livingstone, Edinburgh 1984.

    Google Scholar 

  8. Reuther P, Hertel G, Ricker K, Bürkner R. Lungenfunktionsdiagnostik bei myasthenia gravis. Verhandlungen der Deutsche Gesellschaft für Innere Medizin 1978; 84:1579–1582.

    Google Scholar 

  9. Kuks JBM, Oosterhuis HJGH. Disorders of the neuromuscular junction: outcome measures and clinical scales. In: Guiloff RJ (ed.): Clinical trials in neurology. Springer, London 2001, pp 485–499.

    Google Scholar 

  10. Oppenheim H. Die Myasthenische Paralyse (Bulbärpara1yse ohne anatomischen Befund). Berlin, S Karger 1901.

    Google Scholar 

  11. Oosterhuis H J G H, Bethlem J. Neurogenic muscle involvement in myasthenia gravis. J Neurol Neurosurg Psychiatry 1973; 36: 244–254.

    Article  Google Scholar 

  12. Osserman KE. Myasthenia Gravis. Grune & Stratton 1958 New York

    Google Scholar 

  13. Oosterhuis HJGH 1964 Studies in myasthenia gravis. J Neurol Sci 1964; 1: 512–546

    Article  Google Scholar 

  14. Schimrigk K, Samland O. Muskelatrophien bei Myasthenia gravis. Der Nervenarzt 1977; 48: 65–68.

    PubMed  CAS  Google Scholar 

  15. Simpson JA. Evaluation of thymectomy in myasthenia gravis. Brain 1958: 81:112–145.

    Article  PubMed  CAS  Google Scholar 

  16. Kinnier Wilson S A. Neurology, vol I, London, Edward Arnolds Co 1940, p 1598.

    Google Scholar 

  17. Oosterhuis HJGH. Myasthenia Gravis. Groningen Neurological Press. 1997

    Google Scholar 

  18. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty year experience in over 1200 patients. Mt Sinai J Med 1971; 34: 497–537.

    Google Scholar 

  19. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Jartezki III A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB. Myasthenia Gravis. Recommendations for clinical research standards. Neurology 2000; 55: 16–23

    Google Scholar 

  20. Schumm F, Wiethoelter H, Fateh-Moghadam A, Dichgans J. Thymectomy in myasthenia gravis with pure ocular symptoms. J Neurol Neurosurg Psychiat 1985; 48: 332–337.

    Article  PubMed  CAS  Google Scholar 

  21. Tucker D M, Roeltgen DP, Wann Ph D Wertheimer RI. Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects. Neurology 1988; 38: 1173–1177 .

    PubMed  CAS  Google Scholar 

  22. Lewis S W, Ron M A, Newsom-Davis J. Absence of central functional cholinergic deficits in myasthenia gravis. J Neurol Neurosurg Psychiatry 1989;52:258.

    Article  PubMed  CAS  Google Scholar 

  23. Whiting PJ, Cooper J, Lindstrom JM. Antibodies in sera from patients with myasthenia gravis do not bind with nicotinic acetylcholine receptors from human brain. J Neuroimmunol 1987; 16: 205

    Article  PubMed  CAS  Google Scholar 

  24. Steiner I, Brenner T, Soffer D, Argov Z. Involvement of sites other than the neuromuscular junction in myasthenia gravis. In Lisak RP (ed.) Handbook of Myasthenia gravis and myasthenic syndromes. Marcel Decker, New York 1994, pp 277–294.

    Google Scholar 

  25. Oosterhuis H J G H. Myasthenia gravis. A review. Clin Neurol Neurosurg 1981; 83:105–135.

    Article  Google Scholar 

  26. Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and the effect of various therapeutic measures. Ann NY Acad Sci 1981; 377: 652–669.

    Article  PubMed  CAS  Google Scholar 

  27. Grob D. Natural history of myasthenia gravis. In: Engel AG (Ed.). Myasthenia gravis and myasthenic disorders. Oxford University Press, New York, 1999; pp 131–145

    Google Scholar 

  28. Beekman R, Kuks J B M, Oosterhuis HJGH. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol Sci 1997;244:112–118.

    Article  CAS  Google Scholar 

  29. Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann NY Acad Sci 1981; 377: 670–677.

    Article  PubMed  CAS  Google Scholar 

  30. Oosterhuis H J G H. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann NY Acad Sci 1981; 377:678–689.

    Article  PubMed  Google Scholar 

  31. Beghi E, Antozzi C, Batocchi AP et al.: Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 1991; 106: 213–220.

    Article  PubMed  CAS  Google Scholar 

  32. Donaldson DH, Ansher M, Horan S, Rutherford RB, Ringel SP. The relationship of age to outcome in myasthenia gravis. Neurology 1990; 40: 786–790

    PubMed  CAS  Google Scholar 

  33. Wittbrodt ET. Drugs and myasthenia gravis. n update. Arch Int Med 1997; 157: 399–408.

    Article  CAS  Google Scholar 

  34. Schalke B. Klinische Besonderheiten bei Myasthenia Gravis Patienten. Akt Neurologie 1998; 25: 528–529

    Google Scholar 

  35. Plauché W C. Myasthenia gravis in pregnancy: an up date. Am J Ob Gyn 1979; 135:691–697.

    Google Scholar 

  36. Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999; 52: 447–452

    PubMed  CAS  Google Scholar 

  37. Leker RR, Karni A, Abramski O. Exacerbation of myasthenia during the menstrual period. J Neurol Sci 1998; 156: 107–111

    Article  PubMed  CAS  Google Scholar 

  38. Borenstein S, Desmedt J E. Temperature and weather correlates of myasthenia fatigue. Lancet 1974; ii: 63–66.

    Article  Google Scholar 

  39. Guttman L. Heat-induced myasthenic crises. Arch Neurol 1980;37:671–672.

    Article  Google Scholar 

  40. Oosterhuis H J G H. The natural course of myasthenia gravis: a longterm follow-up study. J Neurol Neurosurg Psychiatry 1989; 52: 1121–1127.

    Article  PubMed  Google Scholar 

  41. Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark: a longitudinal and comprehensive population survey. Arch Neurol 1991; 48: 733–739.

    Article  PubMed  CAS  Google Scholar 

  42. Storm Mathisen A 1984 Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 70, 274–284.

    Article  PubMed  CAS  Google Scholar 

  43. Aragonès, JM, Bolíbar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I. Myasthenia Gravis. A higher than expected incidence in the elderly. Neurology 2003; 60: 1024–1026.

    PubMed  Google Scholar 

  44. Emilio Romagna Study Group on Clinical and Epidemiological Problems in Neurology: Incidence of myasthenia gravis in the Emilia-Romagna region: A prospective multicenter study. Neurology 1998; 51: 255–258.

    Google Scholar 

  45. D’ Alessandro R, Granieri E, Benassi G, Tola M R, Casmiro M, Mazzanti B, Gamberini G, Caniatti L. Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurol Scand 1991; 2: 83–88.

    Article  Google Scholar 

  46. Phillips LH, Tomer JC, Anderson MS, Cox GM. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992; 42: 1888–1893.

    PubMed  Google Scholar 

  47. Pirskanen R. Genetic aspects in myasthenia gravis, a family study of 264 Finnish patients. Acta Neurol Scand 1977; 56: 365–388

    Article  PubMed  CAS  Google Scholar 

  48. Sorensen TT, Holm E B 1989 Myasthenia gravis in the county of Viborg, Denmark. Eur Neurol 29: 177–179.

    Article  PubMed  CAS  Google Scholar 

  49. Robertson NP, Deans J, Compston DAS. Myasthenia Gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998; 65: 492–496.

    Article  PubMed  CAS  Google Scholar 

  50. Niks EH, Kuks JBM, Verschuuren JJGM. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands. J Neurol Neurosurg Psychiatry. 2007 Apr; 78(4):417–8.

    Google Scholar 

  51. Grob D, Arsura E L, Brunner N G, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 1987; 505:472.

    Article  PubMed  CAS  Google Scholar 

  52. Mantegazza R, Beghi E, Pareyson D, AntozziC, Peluchetti D, Sghirlanzoni A, Cosi V, Lombardi M, Piccolo G, Tonali P et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol Sci 1990;237:339–344.

    Article  CAS  Google Scholar 

  53. Potagas C, Dellatotas G, Tavernarakis A, Molari H, Mourtzouhou P, Koutra H, Matiaks N, Balakas N. Myasthenia Gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population. J Neurol. 2004 Jan;251(1):116–7.

    Google Scholar 

  54. Matsuda M, Dohi-Iijima N, Nakamura A, Sekijima Y, Moriat H, Matsuzawa S, Sato S, Yahikozawa H, Tabata K, Yanagawa S, Ideda S. Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano prefecture, Japan. Internal Medicine 2005; 44: 572–577.

    Article  PubMed  Google Scholar 

  55. Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 2005; 65: 928–930.

    Article  PubMed  CAS  Google Scholar 

  56. Fukuyama Y, Hirayama Y, Osawa M. Epidemiological and clinical features of childhood myasthenia gravis in Japan. Japan Medical Research Foundation University of Tokyo Press, Tokyo 1981 p 19.

    Google Scholar 

  57. Hawkins BR, Yu Y L, Wong V, Woo E, IpM S, Dawkins R L. Possible evidence of a variant of myasthenia gravis based on HLA and acetylcholine receptor antibody in Chinese patients. Quart J Med 1989; 70: 235–241.

    PubMed  CAS  Google Scholar 

  58. Wong V, Hawkins B R, Yu YL. Myasthenia gravis in Hong Kong Chinese. Acta Neurol Scand 1992; 86: 68–72.

    Article  PubMed  CAS  Google Scholar 

  59. Batocchi AP, Evoli A, Palmisani MT, Lo Monaco M, Bartoccioni M, Tonali P. Early onset myasthenia gravis: clinical characteristics and response to therapy. Eur J Pediatr 1990; 150: 66–68

    Article  PubMed  CAS  Google Scholar 

  60. Lindner A, Schalke B, Toyka KV. Outcome of juvenile-onset myasthenia gravis: a retrospective study with long term follow-up of 79 patients. J Neurol 1997; 244: 515–520

    Article  PubMed  CAS  Google Scholar 

  61. Aarli JA. Late-onset Myasthenia Gravis. Arch Neurol 1999; 56: 25–27.

    Article  PubMed  CAS  Google Scholar 

  62. Kuks JBM, Limburg PC, Horst G, Oosterhuis HJGH. Antibodies to skeletal muscle in myasthenia gravis, part 2. Prevalence in non-thymoma patients. J Neurol Sci 1993; 120: 78–81

    Article  PubMed  CAS  Google Scholar 

  63. Bril V, Kojic J, Dhanani A. The long-term clinical outcome of myasthenia gravis in patients with thymoma. Neurology 1998; 51: 1198–1200.

    PubMed  CAS  Google Scholar 

  64. Simpson JA. Myasthenia gravis, a new hypothesis. Scot Med J 1960; 5: 419–436.

    Google Scholar 

  65. Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: autoimmune disease and their relation to thymectomy. Acta Neurol Scand 1989;80:290–295.

    Article  PubMed  CAS  Google Scholar 

  66. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin Immunol Immunopath 1997;84:223–243

    Article  CAS  Google Scholar 

  67. Namba T, Brunner N G, Brown S B, Muguruma M, Grob D. Familial myasthenia gravis. Arch Neurol 1971; 25: 49–60.

    Article  PubMed  CAS  Google Scholar 

  68. Szobor A. Myasthenia gravis: familial occurrence, a study of 1100 myasthenia gravis patients. Acta Medica Hungarica 1989; 4: 13

    Google Scholar 

  69. Behan P O. Immune disease and HLA association with myasthenia gravis. J Neurol Neurosurg Psychiatry 1980; 4: 611–621.

    Article  Google Scholar 

  70. Evoli A, Batocchi AP, Zelano G, Uncini A, Palmisani MT, Tonali P. Familial autoimmune myasthenia gravis: report of four families. J Neurol Neurosurg Psychiat 1995; 58: 729–731.

    Article  PubMed  CAS  Google Scholar 

  71. Bergoffen J, Zmyewski ChM, Fischbeck KH. Familial autoimmune myasthenia gravis. Neurology 1994; 44: 551–554.

    PubMed  CAS  Google Scholar 

  72. Suarez GA, Kelly JJ. The dropped head syndrome. Neurology 1992;42:1625–1627.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University Hospital Groningen, Groningen, The Netherlands

    Jan B.M. Kuks

Authors
  1. Jan B.M. Kuks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kuks, J.B. (2009). Clinical Presentation and Epidemiology of Myasthenia Gravis. In: Myasthenia Gravis and Related Disorders. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-156-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-156-7_5

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-852-2

  • Online ISBN: 978-1-59745-156-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation